• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨免疫学和促炎细胞因子对破骨细胞的影响。

Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts.

机构信息

University of Ljubljana, Faculty of Pharmacy, Department of Clinical Biochemistry, Ljubljana, Slovenia.

出版信息

Biochem Med (Zagreb). 2013;23(1):43-63. doi: 10.11613/bm.2013.007.

DOI:10.11613/bm.2013.007
PMID:23457765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3900089/
Abstract

Bone and immune system are functionally interconnected. Immune and bone cells derive from same progenitors in the bone marrow, they share a common microenvironment and are being influenced by similar mediators. The evidence on increased bone resorption associated with inappropriate activation of T cells such as during inflammation, is well established. However, the molecular mechanisms beyond this clinical observation have begun to be intensively studied with the advancement of osteoimmunology. Now days, we have firm evidence on the influence of numerous proinflammatory cytokines on bone cells, with the majority of data focused on osteoclasts, the bone resorbing cells. It has been shown that some proinflammatory cytokines could possess osteoclastogenic and/or anti-osteoclastogenic properties and can target osteoclasts directly or via receptor activator of nuclear factor kappaB (RANK)/RANK ligand(RANKL)/osteoprotegerin (OPG) system. Several studies have reported opposing data regarding (anti)osteoclastogenic properties of these cytokines. Therefore, the first part of this review is summarizing current evidence on the influence of pro-inflammatory cytokines on osteoclasts and thus on bone resorption. In the second part, the evidence on the role of pro-inflammatory cytokines in osteoporosis and osteoarthritis is reviewed to show that unravelling the mechanisms beyond such complex bone diseases, is almost impossible without considering skeletal and immune systems as an indivisible integrated system.

摘要

骨骼和免疫系统在功能上是相互关联的。免疫细胞和骨细胞都来源于骨髓中的同一祖细胞,它们共享一个共同的微环境,并受到相似介质的影响。在炎症等情况下,T 细胞异常激活导致骨吸收增加的证据已经得到充分证实。然而,随着骨免疫学的发展,超越这一临床观察的分子机制已经开始得到深入研究。如今,我们有确凿的证据表明,许多促炎细胞因子会影响骨细胞,其中大部分数据集中在破骨细胞上,即骨吸收细胞。已经表明,一些促炎细胞因子可能具有破骨细胞生成和/或抗破骨细胞生成特性,并且可以直接或通过核因子 kappaB(NF-κB)受体激活剂(RANK)/RANK 配体(RANKL)/骨保护素(OPG)系统靶向破骨细胞。有几项研究报告了这些细胞因子在(抗)破骨细胞生成特性方面相互矛盾的数据。因此,这篇综述的第一部分总结了促炎细胞因子对破骨细胞进而对骨吸收的影响的现有证据。在第二部分,回顾了促炎细胞因子在骨质疏松症和骨关节炎中的作用的证据,以表明,如果不将骨骼和免疫系统视为一个不可分割的整体系统,那么揭示这些复杂骨骼疾病背后的机制几乎是不可能的。

相似文献

1
Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts.骨免疫学和促炎细胞因子对破骨细胞的影响。
Biochem Med (Zagreb). 2013;23(1):43-63. doi: 10.11613/bm.2013.007.
2
The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues.破骨细胞生成和抗破骨细胞生成的促炎细胞因子之间的关系在人骨质疏松症和骨关节炎骨组织中存在差异。
J Biomed Sci. 2012 Mar 1;19(1):28. doi: 10.1186/1423-0127-19-28.
3
Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).骨及其他组织中的核因子κB受体激活剂配体(RANKL)/核因子κB受体激活剂(RANK)/骨保护素系统(综述)
Mol Med Rep. 2015 May;11(5):3212-8. doi: 10.3892/mmr.2015.3152. Epub 2015 Jan 7.
4
New insights into osteoclastogenic signaling mechanisms.破骨细胞生成信号机制的新见解。
Trends Endocrinol Metab. 2012 Nov;23(11):582-90. doi: 10.1016/j.tem.2012.05.005. Epub 2012 Jun 15.
5
Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.核因子κB受体活化因子配体及肿瘤坏死因子-α在类风湿关节炎骨破坏中的作用
Bone. 2002 Feb;30(2):340-6. doi: 10.1016/s8756-3282(01)00682-2.
6
Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment.骨龛与免疫系统的串扰:作为癌症治疗潜在靶点的骨免疫学信号
Cancer Treat Rev. 2015 Feb;41(2):61-8. doi: 10.1016/j.ctrv.2014.12.001. Epub 2014 Dec 8.
7
Osteoimmunology.骨免疫学
Int Arch Allergy Immunol. 2007;143(1):31-48. doi: 10.1159/000098223. Epub 2006 Dec 22.
8
Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.打破碗花花总皂苷通过抑制破骨细胞生成预防实验性类风湿关节炎中的骨破坏。
Rejuvenation Res. 2015 Dec;18(6):528-42. doi: 10.1089/rej.2015.1688. Epub 2015 Sep 29.
9
Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue.电离辐射刺激骨髓和骨骼组织中促破骨细胞生成基因的表达。
J Interferon Cytokine Res. 2015 Jun;35(6):480-7. doi: 10.1089/jir.2014.0152. Epub 2015 Mar 3.
10
Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.白细胞介素-4和白细胞介素-13对激素和细胞因子刺激的破骨细胞生成及骨吸收的抑制作用,与骨保护素增加、核因子κB受体活化因子配体(RANKL)和核因子κB受体活化因子(RANK)减少相关,且该过程通过信号转导和转录激活因子6(STAT6)依赖途径实现。
J Biol Chem. 2006 Feb 3;281(5):2414-29. doi: 10.1074/jbc.M510160200. Epub 2005 Oct 25.

引用本文的文献

1
Progress in understanding the role and mechanism of miRNAs in osteoporosis.了解微小RNA(miRNA)在骨质疏松症中的作用和机制的研究进展。
Front Endocrinol (Lausanne). 2025 Aug 19;16:1544944. doi: 10.3389/fendo.2025.1544944. eCollection 2025.
2
Role and mechanism of botanical drugs and their metabolites in osteoporosis: new strategies for clinical application.植物药及其代谢产物在骨质疏松症中的作用与机制:临床应用新策略
Front Pharmacol. 2025 Aug 12;16:1530194. doi: 10.3389/fphar.2025.1530194. eCollection 2025.
3
Stress During Lactation: A Hidden Link to Offspring Bone Health.

本文引用的文献

1
Interleukin-1α gene variants influence bone mineral density and the risk of osteoporotic hip fractures in elderly Slovenian people.白细胞介素-1α 基因变异影响老年斯洛文尼亚人群的骨密度和骨质疏松性髋部骨折风险。
Clin Chem Lab Med. 2012 Feb 2;50(8):1379-85. doi: 10.1515/cclm-2011-0589.
2
The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues.破骨细胞生成和抗破骨细胞生成的促炎细胞因子之间的关系在人骨质疏松症和骨关节炎骨组织中存在差异。
J Biomed Sci. 2012 Mar 1;19(1):28. doi: 10.1186/1423-0127-19-28.
3
Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis.
哺乳期压力:与后代骨骼健康的潜在联系。
Calcif Tissue Int. 2025 May 30;116(1):79. doi: 10.1007/s00223-025-01378-6.
4
Expression and significance of cytokines in peripheral blood and bone microenvironment in Kummell's disease, osteoporotic vertebral compression fractures and nonosteoporotic patients.细胞因子在Kummell病、骨质疏松性椎体压缩骨折及非骨质疏松患者外周血和骨微环境中的表达及意义
BMC Musculoskelet Disord. 2025 Mar 10;26(1):232. doi: 10.1186/s12891-025-08472-8.
5
Cell-Type-Specific ROS-AKT/mTOR-Autophagy Interplay-Should It Be Addressed in Periimplantitis?细胞类型特异性的活性氧-蛋白激酶B/雷帕霉素靶蛋白-自噬相互作用——在种植体周围炎中是否应予以关注?
Diagnostics (Basel). 2024 Dec 11;14(24):2784. doi: 10.3390/diagnostics14242784.
6
Employing single-cell RNA sequencing coupled with an array of bioinformatics approaches to ascertain the shared genetic characteristics between osteoporosis and obesity.采用单细胞RNA测序结合一系列生物信息学方法来确定骨质疏松症和肥胖症之间的共同遗传特征。
Bone Joint Res. 2024 Oct 16;13(10):573-587. doi: 10.1302/2046-3758.1310.BJR-2023-0366.R1.
7
Immune-dysregulation harnessing in myeloid neoplasms.髓系肿瘤中的免疫失调调控。
Cancer Med. 2024 Sep;13(17):e70152. doi: 10.1002/cam4.70152.
8
Investigating the influence of titanium particle size and concentration on osteogenic response of human osteoblasts - in vitro study.研究钛颗粒大小和浓度对人成骨细胞成骨反应的影响——体外研究。
Biomater Investig Dent. 2024 Jun 13;11:40843. doi: 10.2340/biid.v11.40843. eCollection 2024.
9
Perturbations in gut microbiota composition in osteoporosis: a systematic review and meta-analysis.骨质疏松症中肠道微生物组成的扰动:系统评价和荟萃分析。
J Bone Miner Metab. 2024 Sep;42(5):551-563. doi: 10.1007/s00774-024-01517-3. Epub 2024 Jun 12.
10
Is there any association between the presence of biomarkers and apical periodontitis? A systematic review.生物标志物的存在与根尖周炎之间是否存在关联?系统评价。
Front Immunol. 2024 May 22;15:1366954. doi: 10.3389/fimmu.2024.1366954. eCollection 2024.
B 细胞产生的白细胞介素-10 对于抑制 Th17/Th1 反应、诱导 T 调节型 1 细胞和减少胶原诱导性关节炎至关重要。
Arthritis Res Ther. 2012 Feb 8;14(1):R32. doi: 10.1186/ar3736.
4
Osteoblast-specific overexpression of human interleukin-7 rescues the bone mass phenotype of interleukin-7-deficient female mice.成骨细胞特异性过表达人白细胞介素-7 可挽救白细胞介素-7 缺陷雌性小鼠的骨量表型。
J Bone Miner Res. 2012 May;27(5):1030-42. doi: 10.1002/jbmr.1553.
5
Transgenic over-expression of interleukin-33 in osteoblasts results in decreased osteoclastogenesis.成骨细胞中白细胞介素-33 的过表达导致破骨细胞生成减少。
Biochem Biophys Res Commun. 2012 Jan 6;417(1):217-22. doi: 10.1016/j.bbrc.2011.11.088. Epub 2011 Nov 27.
6
Evidence for osteocyte regulation of bone homeostasis through RANKL expression.骨细胞通过 RANKL 表达对骨稳态的调节作用的证据。
Nat Med. 2011 Sep 11;17(10):1231-4. doi: 10.1038/nm.2452.
7
OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice.OSCAR 是一种胶原蛋白受体,可在 DAP12 缺陷的人类和小鼠中增强破骨细胞生成。
J Clin Invest. 2011 Sep;121(9):3505-16. doi: 10.1172/JCI45913. Epub 2011 Aug 15.
8
Interleukin-4 inhibits RANKL-induced NFATc1 expression via STAT6: a novel mechanism mediating its blockade of osteoclastogenesis.白细胞介素-4 通过 STAT6 抑制 RANKL 诱导的 NFATc1 表达:一种介导其阻断破骨细胞生成的新机制。
J Cell Biochem. 2011 Nov;112(11):3385-92. doi: 10.1002/jcb.23269.
9
IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass.IL-23 对于关节炎的诱导、破骨细胞的形成和骨量的维持至关重要。
J Immunol. 2011 Jul 15;187(2):951-9. doi: 10.4049/jimmunol.1003986. Epub 2011 Jun 13.
10
IL-12- and IL-18-mediated, nitric oxide-induced apoptosis in TNF-α-mediated osteoclastogenesis of bone marrow cells.白细胞介素-12 和白细胞介素-18 介导的一氧化氮诱导的肿瘤坏死因子-α介导的骨髓细胞破骨细胞发生中的细胞凋亡。
Calcif Tissue Int. 2011 Jul;89(1):65-73. doi: 10.1007/s00223-011-9494-0. Epub 2011 May 25.